Home > Healthcare > Medical Devices > Diagnostic Devices > brain pet mri systems market
Get a free sample of Brain PET-MRI Systems Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Brain PET-MRI Systems Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Advancements in imaging technology within the brain PET-MRI systems have revolutionized the landscape of neuroimaging, offering unprecedented insights into the structure and function of the brain. These systems combine the strengths of PET and MRI, integrating functional metabolic data with high-resolution anatomical images in a single comprehensive scan.
Brain PET-MRI systems industry size was valued at around USD 353.7 million in 2023 and is estimated to record 5.9% CAGR from 2024 to 2032, backed by the rising incidence of neurological disorders.
The hospitals segment is estimated to reach USD 284.2 million by 2032, as brain PET-MRI systems enable hospitals to explore personalized medicine approaches by correlating imaging findings with genetic, molecular, and clinical data.
The brain PET-MRI systems market in the U.S. is projected to reach USD 214.5 million by 2032, as the region boasts robust R&D infrastructure supported by academic institutions, medical centers, and private sector investments.
Aspect Imaging Ltd., Bruker Corporation, Canon Inc., Cubresa Inc., Fonar Corporation, GE HealthCare Technologies, Inc., Hitachi, Ltd., Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, and Siemens Healthineers AG.